Consistent with the effects of ONC‐212 on CXCR4 expression, pre‐treatment of the CLL cells with ONC‐212 significantly (P = .012) reduced the number of viable CLL cells that migrated through the permeable support towards SDF‐1α. This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.